Ellele Health and Predica Diagnostics: White Paper Announcement

We are pleased to announce the release of our latest white paper,

‘A Successful Combination: The Ellele Device from Ellele Health and the HPV Profiler from Predica Diagnostics.’

This white paper reports the outcomes of a collaborative study between Ellele Health and Predica Diagnostics, focusing on a novel approach to cervical cancer screening. Specifically, the investigation evaluates the performance of the Ellele Sampling Device in combination with HPV profiler. When used on DNA samples, this assay employs targeted next-generation sequencing (NGS) for detection and differentiation of 20 high-risk or potentially high-risk HPV strains.

The results underscore the feasibility of integrating the Ellele Sampling Device with Predica Diagnostics’ HPV profiler to improve accessibility, accuracy and clinical outcomes in cervical cancer screening.

Find out more about Predica Diagnostics here.